FDA Drug Application (021629) for APIDRA by SANOFI AVENTIS US

Back to FDA Applications sponsored by SANOFI AVENTIS US

Application Number021629
Product Number001
FormINJECTABLE;IV (INFUSION), SUBCUTANEOUS
Dosage1000 UNITS/10ML (100 UNITS/ML)
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code
Reference Drug
Drug NameAPIDRA
Active IngredientINSULIN GLULISINE RECOMBINANT

Active IngredientCount
List of drugs with Active Ingredient INSULIN GLULISINE RECOMBINANT2


Back to FDA Applications sponsored by SANOFI AVENTIS US